NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 22, Issue 7, Pages 735-746
Publisher
Informa Healthcare
Online
2012-06-15
DOI
10.1517/13543776.2012.697153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
- (2011) Richard Hargreaves et al. Annals of the New York Academy of Sciences
- Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells
- (2011) Fan Feng et al. CELL BIOLOGY INTERNATIONAL
- The NK-1 Receptor: A New Target in Cancer Therapy
- (2011) Miguel Munoz et al. CURRENT DRUG TARGETS
- NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy
- (2011) M. Munoz et al. CURRENT MEDICINAL CHEMISTRY
- NK-1 as a melanoma target
- (2011) Miguel Muñoz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Paravertebral anesthesia: how substance P and the NK-1 receptor could be involved in regional block and breast cancer recurrence
- (2010) Miguel Muñoz et al. BREAST CANCER RESEARCH AND TREATMENT
- A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
- (2010) M. Munoz et al. CURRENT MEDICINAL CHEMISTRY
- Neurokinin-1 receptor antagonists: a comprehensive patent survey
- (2010) Shih-Chung Huang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines
- (2010) Miguel Muñoz et al. LABORATORY INVESTIGATION
- NK-1-receptor-mediated lesion of spinal post-synaptic dorsal column neurons might improve intractable visceral pain of cancer origin
- (2010) Yun Wang et al. MEDICAL HYPOTHESES
- Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
- (2010) Sonja Ständer et al. PLoS One
- The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug
- (2009) Miguel Muñoz et al. INVESTIGATIONAL NEW DRUGS
- Neurokinin 1 Receptor Mediates Membrane Blebbing in HEK293 Cells through a Rho/Rho-associated Coiled-coil Kinase-dependent Mechanism
- (2009) John Meshki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas
- (2009) Toshimasa Akazawa et al. JOURNAL OF NEUROCHEMISTRY
- Expression of substance P and neurokinin-1-receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression
- (2008) Francisco Esteban et al. HISTOPATHOLOGY
- Cell motility through plasma membrane blebbing
- (2008) Oliver T. Fackler et al. JOURNAL OF CELL BIOLOGY
- Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours
- (2008) M.A. González Moles et al. ORAL ONCOLOGY
- Detection of stable N-terminal protachykinin A immunoreactivity in human plasma and cerebrospinal fluid
- (2008) Andrea Ernst et al. PEPTIDES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started